Browse the evidence

Liraglutide has additional benefits in reducing cardiovascular events in patients with type 2 diabetes mellitus.

Liraglutide may be beneficial for patients with T2DM beyond weight loss.

The experimental group experienced significant reductions in low-density lipoprotein (LDL) levels compared to the control group.

Implementing group visits can lead to improved lipid profiles in CAD patients.

Both groups experienced a decrease in per member per month (PMPM) expenses, with a 38% decrease in the experimental group.

Group interventions may also be cost-effective for CAD patients.

GLP-1 receptor agonists (semaglutide, liraglutide) significantly improve cardiovascular biomarkers—including hs-CRP, systolic blood pressure, and lipid profiles—independent of glycemic control.

GLP-1 medications like semaglutide do more than just help you lose weight; they directly improve your heart health markers. They significantly lower systemic inflammation (hs-CRP), improve blood vessel function, lower blood pressure, and improve lipid profiles. These benefits happen even if you don't have diabetes, proving the drug protects your blood vessels directly. You should be aware of the slightly increased risk of gallbladder issues due to rapid weight loss, so your doctor will monitor your baseline risk.

Menopause is associated with a substantial decrease in endogenous oestrogen concentrations and alterations in body weight, adipose tissue distribution, and energy expenditure, which can predispose women to the development of type 2 diabetes mellitus (T2DM).

Practitioners should be aware of the increased risk of T2DM in menopausal women due to hormonal changes.

Hormone Replacement Treatment (HRT) has a favourable effect on glucose homeostasis in women with T2DM.

HRT may be considered for managing glucose levels in menopausal women with T2DM.

Central fat build-up in ordinary/overweight populations is related to increased occurrences of myocardial infarction, heart failure, or all-cause mortality compared to the obese population.

Clinicians should consider fat distribution when assessing cardiovascular risk in patients.

Physical inactivity, sedentary behavior, and unhealthy diet moderately contribute to incident diabetes with population-attributable fractions of 8.59%, 6.35%, and 4.47%, respectively.

Encouraging physical activity and healthy eating can reduce diabetes risk in older adults.

Physical inactivity, unhealthy diet, and current smoking significantly contribute to the risk of major cardiovascular events with population-attributable fractions of 13.34%, 8.70%, and 3.38%, respectively.

Promoting a healthy lifestyle can lower the risk of cardiovascular events in older adults.

Risks of new-onset diabetes and major cardiovascular events increase simultaneously with worsening lifestyle and metabolic health status.

Monitoring and improving lifestyle and metabolic health can mitigate risks of diabetes and cardiovascular events.

There is a strong correlation between differential glycaemic exposure and cardiovascular risk reduction in type 2 diabetes.

Practitioners should consider glycaemic exposure as a key factor in managing cardiovascular risk in diabetes.

A minimum study duration and a minimum gain in HbA1c reduction are necessary to drive a relevant risk reduction in CVD risk.

Clinical interventions should focus on achieving significant HbA1c reductions over adequate durations to effectively reduce cardiovascular risk.

Immobilization significantly reduces muscle fiber and thigh cross-sectional area, isometric knee extensor, and plantarflexor strength in the control group.

Understanding the effects of immobilization can help in designing rehabilitation protocols.

Losses in triceps surae cross-sectional area were greater in the control group compared to the exercise group.

Targeting specific muscle groups during rehabilitation can mitigate atrophy effects.

There were few deviations from the prescribed diet among participants.

Maintaining a structured dietary plan can minimize deviations and support adherence.

The associations between assigned energy level and actual intake were high for all groups.

Understanding the strong correlation between assigned and actual energy intake can help in designing effective dietary interventions.

Mean 11-hour GH concentrations increased in the caloric restriction plus exercise (CR + EX) and low-calorie diet (LCD) groups.

Incorporating exercise with caloric restriction may enhance GH levels.

High-intensity training (HIT) increased Na+ -K+ -ATPase activity by 5.5% in resting muscle.

Implementing high-intensity training can enhance muscle Na+ -K+ -ATPase activity in trained individuals.

Over 10 years, the MTM intervention is anticipated to potentially be associated with 18,257,000 averted hospitalizations and reductions in health care expenditures of $484.5 billion.

Long-term implementation of MTMs could significantly reduce hospitalizations and healthcare costs.

Liquid meal replacements lead to modest reductions in systolic blood pressure of −4.97 mmHg (−7.32 to −2.62).

Using liquid meal replacements may contribute to lowering blood pressure in this population.

GLP1-RA treatment is associated with improvements in mental health-related quality of life compared with placebo (g = 0.15; P < .001).

GLP1-RAs may enhance mental health quality of life in this population.

The incidence of microvascular complications was significantly reduced in the surgery group (11.5%) compared to the control group (46.3%).

Surgical management may significantly lower the risk of microvascular complications in diabetic patients.

Physiologically elevated acute testosterone levels are linked to hypertrophic adaptations in resistance training.

Emphasize the importance of testosterone in resistance training for muscle growth.

Forty-one percent of ILI participants who achieved ≥175 min·wk at year 1 maintained this threshold of PA at year 4.

Maintaining high levels of physical activity is achievable for some individuals following intensive lifestyle interventions.